Hospital-acquired infections (HAIs) remain one of the most persistent and costly challenges in healthcare today, impacting approximately 1 in 31 hospital patients on any given day in the U.S., according to the CDC. In this episode, Kismet Technologies’ CEO Shari Costantini sits down with Microbiology Manager Kelly Ager to explore the science and results behind NanoRAD, a breakthrough surface treatment designed for continuous protection. Drawing from a recent hospital study, Kelly shares the r...
All content for Kismet Tech Talks is the property of Kismet Technologies and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Hospital-acquired infections (HAIs) remain one of the most persistent and costly challenges in healthcare today, impacting approximately 1 in 31 hospital patients on any given day in the U.S., according to the CDC. In this episode, Kismet Technologies’ CEO Shari Costantini sits down with Microbiology Manager Kelly Ager to explore the science and results behind NanoRAD, a breakthrough surface treatment designed for continuous protection. Drawing from a recent hospital study, Kelly shares the r...
Nanozymes vs. Biofilms: Reimaging the Future of Disinfection with Nanozyme Technology
Kismet Tech Talks
27 minutes
11 months ago
Nanozymes vs. Biofilms: Reimaging the Future of Disinfection with Nanozyme Technology
Join us for an enlightening episode of "Nanozymes vs. Biofilms: Reimagining the Future of Disinfection with Nanozyme Technology," where we dive into the cutting-edge science revolutionizing how we think about disinfection, cleanliness and safety. Hosted by Dr. Christina Drake. This episode explores the incredible potential of nanozymes and their unparalleled ability to combat resilient biofilms. Discover how Kismet Technologies is redefining sanitization standards across industries, from heal...
Kismet Tech Talks
Hospital-acquired infections (HAIs) remain one of the most persistent and costly challenges in healthcare today, impacting approximately 1 in 31 hospital patients on any given day in the U.S., according to the CDC. In this episode, Kismet Technologies’ CEO Shari Costantini sits down with Microbiology Manager Kelly Ager to explore the science and results behind NanoRAD, a breakthrough surface treatment designed for continuous protection. Drawing from a recent hospital study, Kelly shares the r...
